Porphyromonas gingivalis: where do we stand in our battle against this oral pathogen?

文献信息

发布日期 2021-02-26
DOI 10.1039/D0MD00424C
影响因子 0
作者

Kaitlind C. Howard, Octavio A. Gonzalez, Sylvie Garneau-Tsodikova


查看原文

摘要

Periodontal diseases, such as gingivitis and periodontitis, are inflammatory diseases triggered by pathogenic bacteria that lead to damage of the soft tissue and bone supporting the teeth. Amongst the identified oral periodontopathogenic bacteria, Porphyromonas gingivalis is able to enhance oral dysbiosis, which is an imbalance in the beneficial commensal and periodontal pathogenic bacteria that induces chronic inflammation. Given the critical role of oral pathogenic bacteria like P. gingivalis in the pathogenesis of periodontitis, local and/or systemic antibacterial therapy has been suggested to treat this disease, especially in its severe or refractory forms. Nevertheless, the majority of the antibacterial agents currently used for the treatment of periodontal diseases are broad-spectrum, which harms beneficial bacterial species that are critical in health, inhibit the growth of pathogenic bacteria, contribute in protecting the periodontal tissues to damage and aid in its healing. Thus, the development of more effective and specific antibacterial agents is needed to control oral pathogens in a polymicrobial environment. The strategies for the development of novel antibacterial agents include natural product isolation as well as synthetic and semi-synthetic methodologies. This review presents an overview of the periodontal diseases gingivitis and periodontitis along with current antibacterial treatment options (i.e., classes of antibacterial agents and the mechanism(s) of resistance that hinder their usage) used in periodontal diseases that specifically target oral pathogens such as P. gingivalis. In addition, to help medicinal chemists gain a better understanding of potentially promising scaffolds, this review provides an in-depth coverage of the various families of small molecules that have been investigated as potential anti-P. gingivalis agents, including novel families of compounds, repositioned drugs, as well as natural products.

相关文献

Surface-enhanced Raman spectroscopy (SERS) characterisation of abasic sites in DNA duplexes

Luca Guerrini

2019-11-05 Communication

DOI: 10.1039/C9AN02040C

Emerging paper microfluidic devices

Bingbing Gao, Xin Li, Yaqiong Yang, Jianlin Chu, Bingfang He

2019-09-18 Critical Review

DOI: 10.1039/C9AN01275C

A one-step colorimetric acid–base titration sensor using a complementary color changing coordination system

Hui Hun Cho, Si Hyun Kim, Jun Hyuk Heo, Young Eel Moon, Young Hun Choi, Dong Cheol Lim, Kwon-Hoon Han

2016-04-21 Paper

DOI: 10.1039/C6AN00744A

Mass spectrometric analysis of PTM dynamics using stable isotope labeled metabolic precursors in cell culture

Alienke van Pijkeren, Rainer Bischoff

2019-10-25 Critical Review

DOI: 10.1039/C9AN01258C

Contents list

Front/Back Matter

DOI: 10.1039/C6AN90045C

Ambient electrospray deposition Raman spectroscopy (AESD RS) using soft landed preformed silver nanoparticles for rapid and sensitive analysis

Tripti Ahuja, Atanu Ghosh, Sandip Mondal, Pallab Basuri, Shantha Kumar Jenifer, Pillalamarri Srikrishnarka, Jyoti Sarita Mohanty, Sandeep Bose, Thalappil Pradeep

2019-10-15 Paper

DOI: 10.1039/C9AN01700C

SERS-based immunoassay using gold-patterned array chips for rapid and sensitive detection of dual cardiac biomarkers

Ziyi Cheng, Rui Wang, Yanlong Xing, Linlu Zhao, Jaebum Choo, Fabiao Yu

2019-09-20 Paper

DOI: 10.1039/C9AN01260E

您可能还喜欢

化合物问答

什么是2-氨基戊烷(CAS号:63493-28-7)?

2-氨基戊烷,又名pentan-2-amine,是一种有机化合物,分子式为C5H11NH2。它是一种无色透明液体,有氨味。该化合物在工业和研究中有一定的应用。

63493-28-7pentan-2-amine
化合物问答

反式-4-[4-[[[5-[(3,4-二氟苯基)氨基]-1,3,4-恶二唑-2-基]羰基]氨基]苯基]环己烷乙酸(CAS号:892489-52-0)的物理化学性质是什么?

该化合物为白色固体,分子量为552.31 g/mol。它在水中溶解度较低,在有机溶剂如乙腈、乙酸乙酯中有较好的溶解性。该化合物具有较高的化学稳定性,对酸和碱具有...

892489-52-0Trans-4-[4-[[[5-[(3,...
化合物问答

如何处理含有Pyrotinib dimaleate(CAS号:1397922-61-0)的废料?

处理含有Pyrotinib dimaleate 的废料时,应遵循当地的法规要求。首先,收集废料并进行分类,确保没有与其他化学品混合。然后,采取适当的物理和化学处...

1397922-61-0(2E)-N-(4-{[3-Chloro...
化合物问答

在合成中是否有4-(5-5-乙基-1,2,4-噁二唑-3-基)苯甲酸乙酯(CAS号:1166756-79-1)的替代品?

在合成过程中,可以考虑使用其他结构类似的化合物作为替代品,例如苯甲酸酯类化合物,如2-乙基-5-甲基噁二唑基苯甲酸乙酯等。这些替代品可能具有相似的化学性质,但在...

1166756-79-1Ethyl 4-(5-ethyl-1,2...
化合物问答

如何处理含有1-((叔丁氧基羰基)氨基)环丁烷甲酸甲酯(CAS号:880166-10-9)的废料?

处理含有该化合物的废液时,应先确保其完全反应并转化为无害物质。对于未反应的化合物,建议采用中和处理后进行蒸馏回收,剩余物可使用化学氧化法或焚烧法进行无害化处理。...

880166-10-9Methyl 1-({[(2-methy...
化合物问答

2-({[3,5-二(三氟甲基)苯基]磺酰基}氨基)-4-(甲基硫代)丁酸甲酯(CAS号:175202-21-8)的市场或研究趋势如何?

目前该化合物主要应用于药物合成领域,尤其在开发新型抗癌药物方面具有潜在应用。随着制药行业的持续发展,对于高效、低毒的合成中间体需求增加,预计该化合物的研究和应用...

175202-21-8Methyl N-{[3,5-bis(t...
化合物问答

N,N-乙烯双(碘乙酰胺)(CAS号:7250-43-3)的物理化学性质是什么?

N,N-乙烯双(碘乙酰胺)是一种白色或类白色固体,易溶于乙醇、丙酮等有机溶剂,但在水中溶解度较低。该化合物具有较高的反应活性,可以与其他含有活性氢的化合物发生酰...

7250-43-3N,N'-1,2-Ethanediylb...
化合物问答

7-Fluoro-1H-spiro[furo[3,4-c]pyridine-3,4'-piperidine](CAS号:1283090-73-2)通常如何合成?

该化合物可以通过环合反应合成,首先合成吡啶和哌啶的衍生物,然后在合适的条件下进行环合反应得到目标化合物。常用的催化剂包括某些金属盐类,产率一般在70%-90%之...

1283090-73-27-Fluoro-1H-spiro[fu...
化合物问答

处理3-乙酰滇乌碱(CAS号:80787-51-5)时应注意哪些实验室安全事项?

在处理3-乙酰滇乌碱时,应穿戴适当的个人防护装备(PPE),如实验服、手套(丁腈手套或PVC手套)、护目镜和口罩。实验应在通风橱中进行,以减少吸入或皮肤接触的风...

80787-51-54-Methylaconitane-1,...
化合物问答

如何储存2-溴-5-硝基-4-羧酸(CAS号:1053655-82-5)?

2-溴-5-硝基-4-羧酸应存放在阴凉、干燥、通风良好的地方,远离火源和热源。避免与还原剂、碱性物质接触。储存容器应密封,防止吸湿。

1053655-82-52-Bromo-5-nitropyrid...
免责声明
本页面提供的学术期刊信息仅供参考和研究使用。我们与任何期刊出版商均无关联,也不处理投稿事宜。如有投稿相关咨询,请直接联系相关期刊出版商。
如发现页面信息有误,请发送邮件至 support@chemtradehub.com 联系我们。我们将及时核实并处理您的问题。